We have located links that may give you full text access.
Combined Pulmonary Fibrosis and Emphysema (CPFE) in a Connective Disease.
Chest 2014 March 2
SESSION TITLE: ILD Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: A 35-year-old African patient goes to pneumologist because of abnormal chest X-ray (during tuberculosis screening at work).
CASE PRESENTATION: The CT scan showed extensive emphysema bubbles and sub pleural interstitial disease. The patient is non-smoking and serum 1- alpha antrypsine is normal. Raynaud's phenomenon is present for many years and exertional dyspnea (Sadoul 2). Pulmonary auscultation revealed no crackles. Laboratory tests showed a serum antinuclear factor (FAN) to 1/640 with a specific anti SCL 70 ( 117U) suggesting scleroderma. Lung volumes can be described as normal, but the diffusion capacity is deeply lowered ( DLCO 41 % PV). The walk test six-minute walk, the patient desaturated so deeply (SaO2 97% at rest and 79 % at the end of effort with an evaluation of 5 dyspnea on the Borg scale). This presentation is not usual, it was decided to conduct lung biopsies by VAT. Histological examination shows real damage emphysema but also nonspecific infiltrative lung.
DISCUSSION: In the literature, the concomitant presence of emphysema in patients, non-smokers, with systemic sclerosis has been described. A murine model that has a duplication of the fibrillin 1 gene resembles those observations. The possibility of abnormalities of surfactant proteins has been reported in the CPFE. Of course, in this case, environmental origin emphysema may also be suspected (use of wood-burning oven in Africa). Treatment of cellular NSIP is atypical with scleroderma because of the risk of «renal crisis» induced by high corticoid dosis. It consists of low doses of cortisone associated with intravenous cyclophosphamid.
CONCLUSIONS: The diagnosis of cellular NSIP in scleroderma is confirmed and Combined pulmonary fibrosis and emphysema (CPFE) syndrome is identified in a non smoker african female.Reference #1: Curr Opin Pulm Med 2012 sep; 18 (5): 418-27. Combined pulmonary fibrosis and emphysema in connective tissue disease. Cottin V, Cordier JE.Reference #2: Arthritis Rheum. 2011; 63 (1): 295-304. Cottin V, Nunes H, Mouthon L, et al. Groupes d'Etudes et de recherche sur les maladies « Orphelines » Pulmonaires. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease.Reference #3: Am Rev Respir Dis 1981 ; 123 : 680-5. Szapiel SV, FulmerJD, HunninghakeGW, Elson NA, KawanamiO, Ferrans VJ et al. Hereditary emphysema in the tight-skin.
DISCLOSURE: The following authors have nothing to disclose: Olivier Gilbert, Alain Van Meerhaeghe, Myriam Remmelink, Benjamin Bondue, Matteo Cappello, Paul Devuyst, Philippe PierardNo Product/Research Disclosure Information.
CASE PRESENTATION: The CT scan showed extensive emphysema bubbles and sub pleural interstitial disease. The patient is non-smoking and serum 1- alpha antrypsine is normal. Raynaud's phenomenon is present for many years and exertional dyspnea (Sadoul 2). Pulmonary auscultation revealed no crackles. Laboratory tests showed a serum antinuclear factor (FAN) to 1/640 with a specific anti SCL 70 ( 117U) suggesting scleroderma. Lung volumes can be described as normal, but the diffusion capacity is deeply lowered ( DLCO 41 % PV). The walk test six-minute walk, the patient desaturated so deeply (SaO2 97% at rest and 79 % at the end of effort with an evaluation of 5 dyspnea on the Borg scale). This presentation is not usual, it was decided to conduct lung biopsies by VAT. Histological examination shows real damage emphysema but also nonspecific infiltrative lung.
DISCUSSION: In the literature, the concomitant presence of emphysema in patients, non-smokers, with systemic sclerosis has been described. A murine model that has a duplication of the fibrillin 1 gene resembles those observations. The possibility of abnormalities of surfactant proteins has been reported in the CPFE. Of course, in this case, environmental origin emphysema may also be suspected (use of wood-burning oven in Africa). Treatment of cellular NSIP is atypical with scleroderma because of the risk of «renal crisis» induced by high corticoid dosis. It consists of low doses of cortisone associated with intravenous cyclophosphamid.
CONCLUSIONS: The diagnosis of cellular NSIP in scleroderma is confirmed and Combined pulmonary fibrosis and emphysema (CPFE) syndrome is identified in a non smoker african female.Reference #1: Curr Opin Pulm Med 2012 sep; 18 (5): 418-27. Combined pulmonary fibrosis and emphysema in connective tissue disease. Cottin V, Cordier JE.Reference #2: Arthritis Rheum. 2011; 63 (1): 295-304. Cottin V, Nunes H, Mouthon L, et al. Groupes d'Etudes et de recherche sur les maladies « Orphelines » Pulmonaires. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease.Reference #3: Am Rev Respir Dis 1981 ; 123 : 680-5. Szapiel SV, FulmerJD, HunninghakeGW, Elson NA, KawanamiO, Ferrans VJ et al. Hereditary emphysema in the tight-skin.
DISCLOSURE: The following authors have nothing to disclose: Olivier Gilbert, Alain Van Meerhaeghe, Myriam Remmelink, Benjamin Bondue, Matteo Cappello, Paul Devuyst, Philippe PierardNo Product/Research Disclosure Information.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app